Sam was just 12 months old when he was diagnosed with haemophilia – a serious, inherited bleeding disorder in which a person’s blood does not clot properly. His parents suspected something ‘wasn’t quite right’ around the time he started crawling and began developing severe bruising on his hands, face and body. After countless visits to GPs and paediatricians, Sam was finally diagnosed with haemophilia A, the most common form of bleeding disorder.1 To make matters worse, Sam also has ‘inhibitors’, which means the most common type of treatment (FVIII treatment) is not effective for him.
Up to two in three people living with haemophilia have a family history of the disease.2 Although Sam’s mum then discovered she was a carrier of haemophilia, he was the first member of his family known to be living with the disease.
None of the sons will have haemophilia. All of the daughters will carry the gene. Some might have symptoms.2
There is a 50% chance at each birth that a son will have haemophilia.. There is a 50% chance at each birth that a daughter will carry the gene. Some might have symptoms.2
Now aged 31, insurance broker and avid traveller Sam, shares his story of how he has embraced life and all its challenges, despite his physical limitations, and ongoing battle with several long-term haemophilia-related complications.
“I always remember a normal childhood. My parents never wrapped me in cotton wool. They never told me, ‘no you can’t do that’ and they didn’t allow me to worry about the ‘what ifs’,” Sam recalls.
“And while for many years I tried to avoid contact sports, I still had a skateboard, a bike and a scooter, and I played with my friends like any other normal kid.”
“I also remember my trips travelling the country with my family,” Sam recalls. “And, while these trips were not uneventful, I still did a lot of things – I climbed to the top of Uluru; I walked the Three Sisters in the Blue Mountains; went to Perth; explored South Australia; travelled the Great Ocean Road; and was dragged through the waters of the Barrier Reef when I couldn’t walk. While it affected things, it didn't stop us doing as much as we could.”
However, behind this ‘normal’ life, Sam’s childhood and early teens involved almost weekly visits to hospital emergency, or admission for multiple days at a time, after a fall from his bike or a playground injury.
“Sometimes I would run around the playground at lunchtime, and suddenly start limping. That usually signalled my last day at school for the week.
“While all of my classmates were attending school five days a week, I was lucky to make even two-to-three days a week, which made it really hard to keep up,” Sam said.
While Sam is upbeat about his life, he did experience two particularly low points. When he was 12, he received an infected blood product from which he developed hepatitis C. While he has recently been cured of the disease, it has nonetheless, caused irreversible damage to his liver.
Then, at 16, Sam spent five-and-a-half months in hospital undergoing a ‘tolerisation’ process to enable his body to accept FVIII treatment. Following this, Sam and his family decided to take a well-earned break. But while on holiday, Sam’s port-a-cath (vein access device) became infected, resulting in septicaemia, or blood poisoning. This resulted in yet another five-month-long hospital stay, which prevented Sam from graduating year 10, forcing him to repeat the year.
“I just wanted school to be over! I wasn’t really focusing on achieving good academic results at the time. I just wanted to enjoy my last years at school and have fun,” said Sam.
Finally graduating from year 12 and finishing school enabled Sam to focus on his love of travel – he has travelled through Europe, the United States and Japan over the years. He was later granted the opportunity to attend two international events organised by World Federation of Hemophilia, as a representative of Haemophilia Foundation Australia, the first in Panama in 2017 and the second in Myanmar in 2019.
Now working full-time as an insurance broker, Sam’s condition is well managed thanks to advances in haemophilia treatment over the years. However, he still has to contend with the long-term effects of unmanaged haemophilia from his younger years, including arthritis in his ankles and an elbow caused by previous bleeds into joints.
That aside, Sam says he’s doing “really well”. He says: “You can’t sit and pretend you’re not affected by it but you can’t let it stop you from being who you want to be.
“Obviously living with haemophilia does affect some aspects of my life, because there are some things I just can’t physically do. So, I like to be prepared, should something go wrong,” said Sam.
Over the years, Sam has been involved with
“Get out there and do as much as you can and just deal with the issues that arise. Don’t limit yourself,” he says.
HFA Executive Director, Sharon Caris, says that while there is more work to be done, she has high hopes for the future of the Australian haemophilia community.
“While many Australians don’t know much about haemophilia, unless they have a friend or family member living with the disorder, awareness is definitely increasing.
“Fortunately, after many years of few developments, we are now in an exciting time in which new haemophilia treatments and biotechnologies are coming to market,” Sharon said.
“I hope to see these emerging therapies improving the lives of those with haemophilia, and their families, and minimising the disorder’s interference on school attendance, employment and everyday life.
“Haemophilia Foundation will continue to work with decision makers to ensure our community’s voice is heard, and that Australians living with haemophilia have choice and access to the best possible care,” said Sharon.
Haemophilia Foundation Australia. About Bleeding Disorders: Haemophilia. Available at:
Haemophilia Foundation Australia. Haemophilia Foundation Australia. Haemophilia. Rev. edn. Melbourne: HFA, 2013. Available at:
Australian haemophilia Centre Directors’ organisation & the National Blood Authority. 2016. Guidelines for the management of haemophilia in Australia. Available at:
Roche Products Pty Limited ABN 70 000 132 865 | Roche Diagnostics Australia Pty Limited ABN 29 003 001 205 | Roche Diabetes Care Australia Pty Limited ABN 69 602 140 278. This website may contain information about products that are not registered for use in your country of residence and may not comply with applicable laws or regulations in that country. We do not take any responsibility for accessing such information in those circumstances. To report a suspected side effect or product complaint associated with the use of a Roche product, visit